MYLAN 2020 MYLAN 2020
Pill imprint MYLAN 2020 MYLAN 2020 has been identified as Piroxicam 20 mg.
Piroxicam is used in the treatment of osteoarthritis; pain; frozen shoulder; temporomandibular joint disorder; rheumatoid arthritis and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy.
Piroxicam 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Piroxicam Images
- Imprint:
-
MYLAN 2020
MYLAN 2020 - Strength:
- 20 mg
- Color:
- Green
- Size:
- 16.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-2020
- Inactive Ingredients:
- silicon dioxide colloidal
gelatin
lactose hydrous
magnesium stearate
microcrystalline cellulose
polyethylene glycol
sodium lauryl sulfate
titanium dioxide
FD&C Green No. 3
D&C Yellow No. 10
FD&C Yellow No. 6
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0743 | UDL Laboratories Inc |
| 68115-0282 | Dispensexpress Inc (repackager) |
| 49999-0074 | Lake Erie Medical and Surgical Supply (repackager) |
| 66267-0168 | Nucare Pharmaceuticals Inc (repackager) |
| 21695-0285 | Rebel Distributors Corp (repackager) |
| 16590-0188 | Stat RX USA LLC (repackager) |
Note: Inactive ingredients may vary.


